Clinical Cardiology
-
Publication Venue For
- Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a "CASPAR like" outcome from VOYAGER PAD.. 45:1143-1146. 2022
- Multimorbidity, functional impairment, and mortality in older patients stable after prior acute myocardial infarction: Insights from the TIGRIS registry.. 45:1277-1286. 2022
- Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitors.. 45:794-801. 2022
- Improving implementation of evidence-based therapies for heart failure.. 45 Suppl 1:S52-S59. 2022
- Proteomic differences among patients with heart failure taking furosemide or torsemide.. 45:265-272. 2022
- National trends in repair for type B aortic dissection.. 44:1058-1068. 2021
- Acute cardiovascular hospitalizations and illness severity before and during the COVID-19 pandemic.. 44:656-664. 2021
- Diabetes association with self-reported health, resource utilization, and prognosis post-myocardial infarction.. 43:1352-1361. 2020
- The impact of chronic kidney disease on outcomes following peripheral vascular intervention.. 43:1308-1316. 2020
- Decision-making regarding primary prevention implantable cardioverter-defibrillators among older adults.. 43:187-195. 2020
- Heart failure with preserved ejection fraction: New approaches to diagnosis and management.. 43:145-155. 2020
- Not your grandparents' cardiac care: The future of geriatric cardiology.. 43:90-91. 2020
- Lower urine sodium predicts longer length of stay in acute heart failure patients: Insights from the ROSE AHF trial.. 43:43-49. 2020
- Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry.. 43:24-32. 2020
- Opportunities for improving use of evidence-based therapy in patients with type 2 diabetes and cardiovascular disease.. 42:1063-1070. 2019
- Wake Forest University long-term follow-up of type 2 myocardial infarction: The Wake-Up T2MI Registry.. 42:592-604. 2019
- Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial.. 42:568-571. 2019
- Association of acute myocardial infarction cardiac arrest patient volume and in-hospital mortality in the United States: Insights from the National Cardiovascular Data Registry Acute Coronary Treatment And Intervention Outcomes Network Registry.. 42:352-357. 2019
- Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes.. 42:256-263. 2019
- Endovascular treatment of femoro-popliteal lesions.. 42:175-183. 2019
- Platelet inhibition to target reperfusion injury trial: Rationale and study design.. 42:5-12. 2019
- The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes.. 41:1259-1267. 2018
- The impact of clinical vs administrative claims coding on hospital risk-adjusted outcomes.. 41:1225-1231. 2018
- Atrial fibrillation in an African-American cohort: The Jackson Heart Study.. 41:1049-1054. 2018
- Impact of lung-function measures on cardiovascular disease events in older adults with metabolic syndrome and diabetes.. 41:959-965. 2018
- Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF.. 41:945-952. 2018
- Sustained sex-based treatment differences in acute coronary syndrome care: Insights from the American Heart Association Get With The Guidelines Coronary Artery Disease Registry.. 41:758-768. 2018
- Antithrombotic therapy in peripheral artery disease: A review of the EUCLID trial results and current ongoing trials.. 41:137-143. 2018
- Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial.. 41:39-45. 2018
- Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study.. 40:1197-1204. 2017
- Cardiovascular adverse events in the drug-development program of bupropion for smoking cessation: A systematic retrospective adjudication effort.. 40:899-906. 2017
- Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.. 40:746-751. 2017
- Management of newly treated diabetes in Medicare beneficiaries with and without heart failure.. 40:38-45. 2017
- Antianginal medications and long-term outcomes after elective catheterization in patients with coronary artery disease.. 39:721-727. 2016
- Prasugrel Use Following PCI and Associated Patient Outcomes: Insights From the National VA CART Program.. 39:578-584. 2016
- Race and Sex Differences in Management and Outcomes of Patients After ST-Elevation and Non-ST-Elevation Myocardial Infarct: Results From the NCDR.. 39:585-595. 2016
- Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial.. 39:497-506. 2016
- Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial.. 39:329-337. 2016
- The Association of Transfer Rate From Hospitals Without Revascularization Capabilities and Mortality Risk for Older Non-ST-Segment Elevation Myocardial Infarction Patients.. 38:733-739. 2015
- The Contemporary Use of Angiography and Revascularization Among Patients With Non-ST-Segment Elevation Myocardial Infarction in the United States Compared With South Korea.. 38:708-714. 2015
- Cognitive and Physical Function by Statin Exposure in Elderly Individuals Following Acute Myocardial Infarction.. 38:455-461. 2015
- Comparative Effectiveness of Medical Therapy, Supervised Exercise, and Revascularization for Patients With Intermittent Claudication: A Network Meta-analysis.. 38:378-386. 2015
- Prognostic implications of low level cardiac troponin elevation using high-sensitivity cardiac troponin T.. 38:230-235. 2015
- Characterizing major bleeding in patients with nonvalvular atrial fibrillation: a pharmacovigilance study of 27 467 patients taking rivaroxaban.. 38:63-68. 2015
- The impact of processes of care on myocardial infarct size in patients with ST-segment elevation myocardial infarction: observations from the CRISP-AMI trial.. 38:25-31. 2015
- Comparison of clinical trial outcome patterns in patients following acute coronary syndromes and in patients with chronic stable atherosclerosis.. 37:337-342. 2014
- A reevaluation of the costs of heart failure and its implications for allocation of health resources in the United States.. 37:312-321. 2014
- Quality of care for patients with acute coronary syndromes as a function of hospital revascularization capability: Insights from get with the guidelines-CAD.. 37:285-292. 2014
- Combined use of warfarin and oral P2Y12 inhibitors in patients with atrial fibrillation and acute coronary syndrome.. 37:152-159. 2014
- Doppler-detected valve movement in aortic stenosis: a predictor of adverse outcome.. 37:167-171. 2014
- Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry.. 37:7-13. 2014
- Postdischarge international normalized ratio testing and long-term clinical outcomes of patients with heart failure receiving warfarin: findings from the ADHERE registry linked to Medicare claims.. 36:757-765. 2013
- Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry.. 36:721-727. 2013
- Relationship of race/ethnicity with door-to-balloon time and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: findings from Get With the Guidelines-Coronary Artery Disease.. 36:749-756. 2013
- Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.. 36:611-620. 2013
- Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims.. 35:649-657. 2012
- Completion of guideline-recommended initial evaluation of atrial fibrillation.. 35:585-593. 2012
- Reperfusion strategies and quality of care in 5339 patients age 80 years or older presenting with ST-elevation myocardial infarction: analysis from get with the guidelines-coronary artery disease.. 35:632-640. 2012
- Increasing proportion of clinical trials using noninferiority end points.. 35:522-523. 2012
- Quality of care and outcomes among patients with acute myocardial infarction by level of kidney function at admission: report from the get with the guidelines coronary artery disease program.. 35:541-547. 2012
- Lack of association between electronic health record systems and improvement in use of evidence-based heart failure therapies in outpatient cardiology practices.. 35:187-196. 2012
- Comparison of the prognostic value of peak creatine kinase-MB and troponin levels among patients with acute myocardial infarction: a report from the Acute Coronary Treatment and Intervention Outcomes Network Registry-get with the guidelines.. 35:424-429. 2012
- Trends in smoking cessation counseling: experience from American Heart Association-get with the guidelines.. 35:396-403. 2012
- Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims.. 34:682-688. 2011
- Use of guideline-recommended therapies for heart failure in the Medicare population.. 33:400-405. 2010
- Safety of selective serotonin reuptake inhibitor use prior to coronary artery bypass grafting.. 33:E94-E98. 2010
- Influence of clinical trial participation on subsequent antithrombin use.. 33:E49-E55. 2010
- Gender differences in the treatment of non-ST-segment elevation myocardial infarction.. 33:99-103. 2010
- Prehospital electrocardiograms (ECGs) do not improve the process of emergency department care in hospitals with higher usage of ECGs in non-ST-segment elevation myocardial infarction patients.. 32:668-675. 2009
- Early treatment for non-ST-segment elevation acute coronary syndrome is associated with appropriate discharge care.. 32:519-525. 2009
- Hypercholesterolemia paradox in relation to mortality in acute coronary syndrome.. 32:E22-E28. 2009
- The usage patterns of cardiac bedside markers employing point-of-care testing for troponin in non-ST-segment elevation acute coronary syndrome: results from CRUSADE.. 32:498-505. 2009
- Response to Relationship of race/ethnicity with door-to-balloon time and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: Findings from Get With the Guidelines-Coronary Artery Diseases. Authors' reply.. 37:323. 2014